Clinical Trial Update: The Functional Consequences of the CTNS-deletion for the TRPV1-receptor in Cystinosis Patients [EARLY_Phase 1]

View source ↗

Summary

An early-phase clinical trial investigated how CTNS deletion affects TRPV1 receptor function in patients with cystinosis; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystinosis

Snippet

Sponsor: Universitaire Ziekenhuizen KU Leuven | Conditions: Cystinosis | EARLY_Phase 1 | Status: COMPLETED